Tesamorelin and sermorelin preserve and build lean mass, ensuring that weight loss comes preferentially from fat, especially the dangerous visceral fat
Mechanism With Specific Numbers The honest answer is that no single receptor has been conclusively identified as the primary target of BPC-157 in peer-reviewed literature
Drug Testing and Analysis 9:14901498 Duzel A, Vlainic J, Antunovic M, Malekinusic D, Vrdoljak B, Samara M, Gojkovic S, Krezic I, Vidovic T, Bilic Z, Knezevic M (2017) Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: new insights
Each component (BPC-157, TB-500) is not FDA-approved and was removed from 503B bulk-compounding eligibility in 2024